Bio-IT World June 3, 2025
Deborah Borfitz

Although not often counted among the major chronic diseases, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are both highly prevalent and uniquely challenging because the underlying causes are not fully understood, treatment needs to be personalized, and the often-invisible nature of the symptoms can be stigmatizing. Long COVID alone—barely a recognized disease five years ago—affects about 400 million patients’ lives and has an annual economic impact equivalent to about one percent of the global economy (Nature Medicine, DOI: 10.1038/s41591-024-03173-6).

An astounding 250 symptoms affecting most of the major organs of the body have been linked to long COVID. That unsettling list has some crossover with the experience of ME/CFS patients given that the two conditions...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Healthcare System, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Public Health / COVID
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article